EWA
JBIO

EverSource Wealth Advisors’s Jade Biosciences JBIO Stock Holding History

EverSource Wealth Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Buy
1,859
+1,858
+185,800% +$38.7K ﹤0.01% 1899
2026
Q1 		$14 Sell
1
-88
-99% -$1.27K ﹤0.01% 4367
2025
Q4 		$1.37K Buy
89
+88
+8,800% +$1.03K ﹤0.01% 3621
2025
Q3 		$9 Sell
1
-6
-86% -$49 ﹤0.01% 4305
2025
Q2 		$70 Buy
7
+6
+600% +$204 ﹤0.01% 4164
2025
Q1 		$75 Buy
+1
New +$88 ﹤0.01% 3861

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EverSource Wealth Advisors's JBIO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Jade Biosciences (JBIO) stake by 185,800% in Q2 2026, buying an estimated $38.7K and bringing the position to 1,859 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

EverSource Wealth Advisors first reported a position in JBIO in Q1 2025 and has held it in 6 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • EverSource Wealth Advisors held 1,859 shares of Jade Biosciences worth $41.3K as of Q2 2026.
  • EverSource Wealth Advisors bought 1,858 Jade Biosciences shares in Q2 2026, an estimated $38.7K.
  • Jade Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1899 holding.
  • EverSource Wealth Advisors first reported a position in Jade Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.